BROOMALL, PA--(Marketwired - Sep 9, 2015) - PeriRx LLC, a premier developer of breakthrough, non-invasive, oral diagnostic technology, has officially launched SaliMark™ OSCC, an advanced molecular DNA ...
The study performed scRNA-seq from 13 cancerous tissues of OSCC, 3 precancerous oral leukoplakia and 8 adjacent normal samples to systematically survey the cellular diversity of malignant ...
Molecular landscape of oral squamous cell carcinoma: novel biomarkers and therapeutic targets. (A) Mendelian randomization analysis identified 73 pairs of causal risk. (B) Scatter plots of Mendelian ...
Head and neck cancer (HNC) is a devastating disease associated with tobacco smoking. Tobacco smoke-related mRNA phenotypes in HNC were previously documented in vivo and may be differentially expressed ...
Oral cancer often arrives quietly but leaves a devastating mark. Among the many forms it can take, oral squamous cell carcinoma (OSCC) stands out as the most common and one of the most dangerous. Its ...
Oral cancer patients may show different bacteria, viruses, and fungi in their saliva, suggesting an imbalance in the microbiota may aid in the development of oral squamous cell carcinoma (OSCC), ...
Pinaki Bose, a cancer researcher at the University of Calgary and corresponding author of this paper, studies head and neck cancers including the most common of these called oral squamous cell ...
The Israeli Ministry of Health (IL MOH) has approved BeiGene’s TEVIMBRA (tislelizumab) as a monotherapy to treat adults with unresectable or metastatic oesophageal squamous cell carcinoma (OSCC) who ...
Phase I trial of safety of combining BCG with pembrolizumab in patients with high grade superficial bladder cancer unresponsive to previous intravesical therapy. This is an ASCO Meeting Abstract from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results